Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AFATINIB for K-ras gene mutation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where AFATINIB was used for K-ras gene mutation.

Most Reported Side Effects for AFATINIB

Side Effect Reports % Deaths Hosp.
Diarrhoea 2,001 32.9% 351 984
Malignant neoplasm progression 1,622 26.7% 445 283
Rash 808 13.3% 131 315
Stomatitis 468 7.7% 77 234
Death 443 7.3% 443 63
Nausea 430 7.1% 69 280
Decreased appetite 412 6.8% 85 255
Vomiting 381 6.3% 67 271
Paronychia 344 5.7% 62 133
Dehydration 323 5.3% 56 276
Fatigue 256 4.2% 52 128
Metastases to central nervous system 248 4.1% 72 58
Asthenia 221 3.6% 46 151
Off label use 204 3.4% 64 37
Drug ineffective 203 3.3% 31 47

Other Indications for AFATINIB

Non-small cell lung cancer (2,010) Product used for unknown indication (916) Lung adenocarcinoma (876) Lung neoplasm malignant (824) Egfr gene mutation (780) Non-small cell lung cancer metastatic (285) Lung adenocarcinoma stage iv (146) Adenocarcinoma (144) Squamous cell carcinoma of head and neck (76) Non-small cell lung cancer stage iv (74)

Other Drugs Used for K-ras gene mutation

SOTORASIB (752) AMG-510 (173) IRINOTECAN (40) PANITUMUMAB (36) CETUXIMAB (29) PEMBROLIZUMAB (28) BEVACIZUMAB (19) DALOTUZUMAB (18) CARBOPLATIN (17) FLUOROURACIL (17)

Related Pages

AFATINIB Full Profile All K-ras gene mutation Drugs AFATINIB Demographics AFATINIB Timeline